Skip to Content

Maven Brands Inc TRLFF

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TRLFF is trading at a 53% discount.
Price
$0.01
Fair Value
$5.32
Uncertainty
Extreme
1-Star Price
$6.62
5-Star Price
$2.65
Economic Moat
Xbym
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRLFF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.04
Bid/Ask
$0.01 / $0.02
Market Cap
$456,831.26
Volume/Avg
2,500 / 4,814

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market under Canada's Marihuana for Medical Purposes Regulations program administered by Health Canada. The company is launching an innovative services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. Its services will be designed to support craft growers on a path to the regulated market and will operate from the True Leaf Campus facility located in Lumby, British Columbia.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
TRLFF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
TRLFF

Financial Strength

Metric
TRLFF
Quick Ratio
0.01
Current Ratio
0.10
Interest Coverage
−0.22
Quick Ratio
TRLFF

Profitability

Metric
TRLFF
Return on Assets (Normalized)
−14.24%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−3.77%
Return on Assets
TRLFF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AFkvlltcxBkt$70.0 Bil
MKKGY
Merck KGaA ADRJqsgvywdlKnbqhwg$68.1 Bil
HLN
Haleon PLC ADRVmlfgvfqKwvhx$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRZxyqzkthJlg$14.3 Bil
VTRS
Viatris IncVfhxzvtbKcp$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYsztqrfnjLwgm$12.0 Bil
CTLT
Catalent IncGgdqdpvvpFtqqkdx$10.1 Bil
PRGO
Perrigo Co PLCQbnnfyxRkwgq$4.1 Bil
CURLF
Curaleaf Holdings IncHtjvthqVhft$3.7 Bil
PBH
Prestige Consumer Healthcare IncChyvqjfjhLykjr$3.4 Bil

Sponsor Center